Advertisement
Screener

Canopy Growth Corp (CGC) Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination

2.0 / 5 stars · 16/40 Roast Me

Canopy Growth Corp Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination

Canopy Growth Corp (CGC) reported Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination of CAD 26.40 million for the 12-month period ending 2023-03-31, per its 10-K filed 2025-05-30.

Financial Statements › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Consideration Transferred and Preacquisition Equity Interest in Acquiree

us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1 · last filed 2025-05-30

  • Canopy Growth Corp business combination, consideration transferred, including equity interest in acquiree held prior to combination for fiscal 2023 was 26.40M CAD.
Period endBusiness Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination 12 month
2023-03-3126.40M CAD
10-K · filed 2025-05-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87